A(H1N1) Flu Virus Updates

Vaccine manufacturing giant Sanofi Pasteur opened its doors to the media Wednesday, inviting reporters to a first-of-its-kind, up-close look at its H1N1 flu vaccine production facility.

Sanofi, the only manufacturer licensed to make H1N1 vaccine in the United States, also released its final clinical trial data, a 42-day follow-up of its adult and pediatric trials. According to this latest data, a single dose of H1N1 vaccine induces a strong immune response in adults, but two doses will be needed for children 6 months to 9 years of age. More of the news here...